🔥🐔 BizChicken 🐔🔥

Learn About the Corporations Around You

Sign Up Today!

Sign up for BizChicken and discover more about the corporations around you.

Alumis Inc. Common Stock

Alumis Inc. Common Stock logo
Market Cap: Medium
Employees: Low

ESK-001

Alumis Inc. is a clinical stage biopharmaceutical company focusing on developing and commercializing medicines for autoimmune disorders, including ESK-001 and A-005 TYK2 inhibitors.

Tags: TYK2 inhibitor, autoimmune disorders, biopharmaceutical, clinical stage, neuroinflammation, plaque psoriasis, systemic lupus erythematosus

Website

About | About | Contact | Contact | Careers | Careers | Careers | Careers | Careers | About | About

Symbol: ALMS

Recent Price: $7.52

Industry: Biotechnology

CEO: Mr. Martin Babler Ph.D.

Sector: Healthcare

Employees: 128

Address: 280 East Grand Avenue, South San Francisco, CA 94080

Phone: (650) 231-6625

Last updated: 2024-12-31